Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032447 · ClinicalTrials.gov registry record
Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 45
- Enrollment target
NCT01032447: Clinical Trial study, sponsored by Stanford University.
NCT01032447 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01032447 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Pilot study for assessing the effectiveness of a Navigator program to aid in clinical trial participation amongst the Chinese demographic
Interventions
- BEHAVIORAL Navigator Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-07 |
Why NCT01032447 stopped before completion
NCT01032447 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Navigator Support is the first listed.
NCT01032447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01032447 about?
NCT01032447 is a clinical study titled "Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program". Pilot study for assessing the effectiveness of a Navigator program to aid in clinical trial participation amongst the Chinese demographic
What is the current status of trial NCT01032447?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2010-01. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01032447?
The interventions under investigation include: Navigator Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT01032447?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia